Benfotiamine .

Product Description

Benfotiamine in the offering Benfotiamine, that is dephosphorylated to S-benzoylthiamine by ecto-alkaline phosphatases found in the intestinal mucosa. It is then hydrolyzed by thioesterase in the liver into thiamine. Transketolase activity is promoted by benfotiamine on peripheral tissues.

Technical Specifications:  

• Superlist Name: Benfotiamine
• CAS No.: 22457-89-2
• Formula: C19H23N4O6PS
• Molecular Weight: 466.45
• Synonyms: Milgamma;Neurostop;Nitanevril;S-BenzoylthiamineO-monophosphate;Tabiomyl;Vitanevril;Benzenecarbothioicacid, S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl]ester (9CI);Formamide,N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)-,S-benzoate O-(dihydrogen phosphate) (8CI);8088CB;BTMP;Benzoylthiamine O-monophosphate;Berdi;Betivina;Biotamin;
• EINECS: 245-013-4
• Density: 1.444 g/cm3
• Melting Point: 165 ^oC
• Boiling Point: 745.1 ^oC at 760 mmHg
• Flash Point: 404.4 ^oC
• Solubility: Soluble in water
• Appearance: White crystalline powder
• Molar mass: 466.45 gmol1

• Taking Benfotiamine by mouth for up to 24 weeks at a dose of 600 mg per day may be safe. The most common side effects are stomach distress and skin rash.
• Warnings and precautions while using this product:
• Pregnancy and breast-feeding: Benfotiamine isn't safe to use if you're pregnant or nursing. It's best to keep away from it.